Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart...

download Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

of 40

Transcript of Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart...

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    1/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    2/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    3/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    4/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    5/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    6/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    7/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    8/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    9/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    10/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    11/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    12/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    13/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    14/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    15/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    16/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    17/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    18/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    19/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    20/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    21/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    22/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    23/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    24/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    25/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    26/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    27/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    28/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    29/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    30/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    31/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    32/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    33/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    34/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    35/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    36/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    37/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    38/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    39/40

  • 7/24/2019 Using Virtual Screening Methods to Identify Small Molecule Inhibitors of PCSK9 and Prevent Heart Disease

    40/40


Identification of Small-Molecule Inhibitors of Human Golgi ...

Identification of Small-Molecule Inhibitors of Human Golgi ...

Update on PCSK9 Inhibitors

Update on PCSK9 Inhibitors

Classification of small molecule protein kinase inhibitors based ...

Classification of small molecule protein kinase inhibitors based ...

Small Molecule Ice Recrystallization Inhibitors Enable Freezing of ...

Small Molecule Ice Recrystallization Inhibitors Enable Freezing of ...

Proprotein Convertase Subtilisin Kexin 9 (PCSK9 .../media/azblue/files/... · Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors: PRALUENT™ (alirocumab) subcutaneous injection

Proprotein Convertase Subtilisin Kexin 9 (PCSK9 .../media/azblue/files/... · Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors: PRALUENT™ (alirocumab) subcutaneous injection

Small molecule inhibitors

Small molecule inhibitors

Development of Novel Small Molecule Inhibitors by A ...

Development of Novel Small Molecule Inhibitors by A ...

The Evoluon of PCSK9 inhibitors; Pipedream or Evidence ... · 17.03.2017  · The Evoluon of PCSK9 inhibitors; Pipedream or Evidence based Reality? Kindly supplied by Evan A Stein

The Evoluon of PCSK9 inhibitors; Pipedream or Evidence ... · 17.03.2017  · The Evoluon of PCSK9 inhibitors; Pipedream or Evidence based Reality? Kindly supplied by Evan A Stein

PCSK9 Inhibitors: A View of Clinical Studies · 2013-10-02  · PCSK9 Inhibitors: From Target Discovery to Phase III in 10 Years 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

PCSK9 Inhibitors: A View of Clinical Studies · 2013-10-02  · PCSK9 Inhibitors: From Target Discovery to Phase III in 10 Years 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012

Naturally Occurring PCSK9 Inhibitors - unimi.it

Naturally Occurring PCSK9 Inhibitors - unimi.it

Small Molecule Inhibitors of Inflammatory Caspases-1, -4 ...

Small Molecule Inhibitors of Inflammatory Caspases-1, -4 ...

PCSK9 Inhibitors - Praluent (Alirocumab) and Repatha ...€¦ · PCSK9 Inhibitors Praluent (Alirocumab) and Repatha (Evolocumab) For the Treatment of Familial Hypercholesterolemia

PCSK9 Inhibitors - Praluent (Alirocumab) and Repatha ...€¦ · PCSK9 Inhibitors Praluent (Alirocumab) and Repatha (Evolocumab) For the Treatment of Familial Hypercholesterolemia

Clinical trials of PCSK9 inhibitors for the secondary prevention of … · 2019-06-18 · Inhibitors for the (Secondary) Prevention of Atherosclerotic ... PCSK9 Inhibitors vs. No

Clinical trials of PCSK9 inhibitors for the secondary prevention of … · 2019-06-18 · Inhibitors for the (Secondary) Prevention of Atherosclerotic ... PCSK9 Inhibitors vs. No

PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated ...

PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated ...

Identification of Small-Molecule Inhibitors against Meso-2 ...

Identification of Small-Molecule Inhibitors against Meso-2 ...

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

PCSK9 Inhibitors, The Most Significant Advance in Lipid ...Wilson PCSK9 Inhibitors 25 of the first PCSK9 inhibitors in 2015, Repatha (evolocumab) and Praluent (alirocumab) both indicated

Update on PCSK9 inhibitors and Statin Intolerance...2016/04/03  · Update on PCSK9 inhibitors and Statin Intolerance Dr Amrish Agrawal MD, DM Card, MRCP UK, FRCP(Glas.), FRCP(Edin.)

Update on PCSK9 inhibitors and Statin Intolerance...2016/04/03  · Update on PCSK9 inhibitors and Statin Intolerance Dr Amrish Agrawal MD, DM Card, MRCP UK, FRCP(Glas.), FRCP(Edin.)

Design and Synthesis of Small Molecule Inhibitors against ...

Design and Synthesis of Small Molecule Inhibitors against ...

Novel Small Molecule Inhibitors for the Human Kinesins ...

Novel Small Molecule Inhibitors for the Human Kinesins ...

DyslipidemiaManagement in 2019 Role of PCSK9 inhibitors...• New list price for the proproteinconvertasesubtilisin-kexintype 9 (PCSK9) inhibitor is $5850 a year, down from its original

DyslipidemiaManagement in 2019 Role of PCSK9 inhibitors...• New list price for the proproteinconvertasesubtilisin-kexintype 9 (PCSK9) inhibitor is $5850 a year, down from its original